Filip K. Knop
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management 326
- Diabetes Management and Research 147
- Endocrine and Autonomic Systems top 0.5%
- Surgery top 0.1%
- Pancreatic function and diabetes 170
- Physiology top 0.2%
- Diet and metabolism studies 84
- Pharmacology top 0.2%
- Pharmacology and Obesity Treatment 41
-
- Metabolism, Diabetes, and Cancer 96
-
- Liver Disease Diagnosis and Treatment 52
-
- Diabetes and associated disorders 42
- Co-authors
- Tina VilsbøllJens J. HolstMikkel ChristensenAsger LundLise Lotte GluudSten MadsbadJonatan I. BaggerThure Krarup
- Journals
- Proceedings of the National Academy of Sciences (3 papers)The Lancet (3 papers)Physiological Reviews (1 paper)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Filip K. Knop
528 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Endocrinology, Diabetes and Metabolism 12.4k
- Endocrine and Autonomic Systems 1.3k
- Surgery 7.7k
- Physiology 3.7k
- Pharmacology 2.4k
Countries citing papers authored by Filip K. Knop
This map shows the geographic impact of Filip K. Knop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip K. Knop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip K. Knop more than expected).
Fields of papers citing papers by Filip K. Knop
This network shows the impact of papers produced by Filip K. Knop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip K. Knop. The network helps show where Filip K. Knop may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Filip K. Knop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s diseasebreakdown → | 2025 | 40 |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 23 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 34 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2017 | 75 | |
| 17 | 2016 | 66 | |
| 18 | 2013 | 2 | |
| 19 | Glucagon-like peptide-1 and diabetes treatment | 2009 | 1 |
| 20 | [The benefits of diagnostic imaging in general practice]. | 2006 | 5 |
About Filip K. Knop
Filip K. Knop is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Gastroenterology, having authored 552 papers that have together received 18.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (326 papers), Pancreatic function and diabetes (170 papers), Diabetes Management and Research (147 papers), Metabolism, Diabetes, and Cancer (96 papers), Diet and metabolism studies (84 papers), Liver Disease Diagnosis and Treatment (52 papers), Diabetes and associated disorders (42 papers) and Pharmacology and Obesity Treatment (41 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (12.4k citations), Endocrine and Autonomic Systems (1.3k citations) and Surgery (7.7k citations). Filip K. Knop has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Tina Vilsbøll, Jens J. Holst, Mikkel Christensen, Asger Lund, Lise Lotte Gluud, Sten Madsbad, Jonatan I. Bagger, Thure Krarup, Bolette Hartmann and Nicolai J. Wewer Albrechtsen. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Physiological Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.